Metastatic colorectal cancer
Oncosyne AS focuses on clinical research in metastatic colorectal cancer, with interest in tools that support treatment selection for patients with advanced disease. Its work centers on the use of diagnostic testing to assess drug sensitivity and inform therapeutic decisions in the third-line setting.
- Precision oncology
- Treatment guidance for advanced colorectal cancer
- Drug sensitivity evaluation
The sponsor’s research activity is directed toward generating clinically relevant data for physicians managing resistant or later-stage colorectal cancer.
Diagnostic performance
The company is involved in evaluating a new diagnostic test designed to produce accurate and reliable results for therapy selection. This area of interest reflects a strong emphasis on clinical performance, data quality, and decision support in oncology care.
- Clinical validation of diagnostic tools
- High-quality biomarker assessment
- Physician decision support
Research in this domain is aligned with the development of diagnostic approaches intended to help identify patients most likely to benefit from specific treatments.
